About: Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review
Creator	Luke, \| Gallo, Benjamin Ab, Marin Bs, Ghazal Frank, \| Sellke, W Soliman Mts, B
Source	Medline; PMC
abstract	BACKGROUND: Respiratory complications have been well remarked in the novel coronavirus disease (SARS‐CoV‐2/COVID‐19), yet an emerging body of research indicates that cardiac involvement may be implicated in poor outcomes for these patients. AIMS: This review seeks to gather and distill the existing body of literature that describes the cardiac implications of COVID‐19. MATERIALS AND METHODS: The English literature was reviewed for papers dealing with the cardiac effects of COVID‐19. RESULTS: Notably, COVID‐19 patients with pre‐existing cardiovascular disease are counted in greater frequency in intensive care unit settings, and ultimately suffer greater rates of mortality. Other studies have noted cardiac presentations for COVID‐19, rather than respiratory, such as acute pericarditis and left ventricular dysfunction. In some patients there has been evidence of acute myocardial injury, with correspondingly increased serum troponin I levels. With regard to surgical interventions, there is a dearth of data describing myocardial protection during cardiac surgery for COVID‐19 patients. Although some insights have been garnered in the study of cardiovascular diseases for these patients, these insights remain fragmented and have yet to cement clear guidelines for actionable clinical practice. CONCLUSION: While some information is available, further studies are imperative for a more cohesive understanding of the cardiac pathophysiology in COVID‐19 patients to promote more informed treatment and, ultimately, better clinical outcomes.
has issue date	2020-04-19(xsd:dateTime)
bibo:doi	10.1111/jocs.14538
bibo:pmid	32306491
has license	no-cc
sha1sum (hex)	99512dd1e60af99a7e6617f7118d626bf3963f19
schema:url	https://doi.org/10.1111/jocs.14538
resource representing a document's title	Cardiac involvement in COVID‐19 patients: Risk factors, predictors, and complications: A review
has PubMed Central identifier	PMC7264604
has PubMed identifier	32306491
schema:publication	J Card Surg
resource representing a document's body	covid:99512dd1e60af99a7e6617f7118d626bf3963f19#body_text
is schema:about of	named entity 'body' named entity 'SARS-CoV-2' named entity 'Risk factors' named entity 'Cardiac' named entity 'disease' named entity 'complications' named entity 'cardiac involvement' named entity 'SARS-CoV-2' named entity 'Risk factors' named entity 'cardiac effects' named entity 'China' named entity 'reference limit' named entity 'COVID' named entity 'organ systems' named entity 'cardiovascular disorders' named entity 'myocardial injury' named entity 'blood chemistry' named entity 'cardiac involvement' named entity 'risk factors' named entity 'COVID' named entity 'zymogram' named entity 'lungs' named entity 'COVID-19' named entity 'COVID' named entity 'COVID' named entity 'myocarditis' named entity 'Cardiovascular diseases' named entity 'COVID-19 virus' named entity 'prognosis' named entity 'biomarkers' named entity 'lungs' named entity 'pharmacologic' named entity 'ACE2' named entity 'COVID-19' named entity 'clinical features' named entity 'cardiac insufficiency' named entity 'diabetes' named entity 'COVID-19' named entity 'SARS-CoV' named entity 'troponin' named entity 'COVID' named entity 'pharmacological' named entity 'cardiac involvement' named entity 'host cells' named entity 'troponin' named entity 'cardiovascular' named entity 'COVID-19' named entity 'acute myocardial injury' named entity 'infection' named entity 'elderly patients' named entity 'respiratory tract' named entity 'NIH' named entity 'autopsies' named entity 'myocardial injury' named entity 'lungs' named entity 'infection' named entity 'risk factors' named entity 'coronary heart disease' named entity 'virus' named entity 'COVID' named entity 'viral infections' named entity 'immune systems' named entity 'pneumonia' named entity 'infection' named entity 'pneumonia' named entity 'comorbidities' named entity 'liver' named entity 'lungs' named entity 'COVID-19 disease' named entity 'hypertension' named entity 'myocarditis' named entity 'ICU' named entity 'diabetes' named entity 'Centers for Disease Control and Prevention' named entity 'COVID'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software